Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation

B LONDON, March 31, 2026 /PRNewswire/ — Virax Biolabs Group Limited (NASDAQ: VRAX) (“Virax” or the “Company”) today announced that Virax Biolabs (UK) Limited, its…

posteditor
posteditor
Articles: 27298

Other News